If you are troubling find the best IVF centre in Delhi? No worries when Crysta IVF is available for you especially when it is recognized as a one-stop solution for all your infertility problems. From working on govt guidelines to following the amalgamation of cutting-edge technologies with modern ART labs, Crysta IVF has been idealized as the best IVF centre in Delhi. Here the doctors have more than two decades of experience in delivering progressive results so that every individual can get the best possible treatment to plan for a healthy baby.
A recent Pharmacists' Defence Association (PDA) survey revealed that 80 per cent of its member working in the NHS in England, Wales, and Northern Ireland
rejected the NHS pay award.
"For the first time in the history of our union, members have told us they are so angry that they would not rule out industrial action in conjunction with other
NHS unions," said Paul Moloney, PDA Union national officer.
"It is important that, whoever is to lead the government, they listen to this message and act now to ensure our members and others in the NHS do not face swinging
cuts to their standard of living."
PDA members were asked whether they would support industrial action if they had rejected the award and if other NHS unions would be taking industrial action. 58 per
cent of those responding said they would support the PDA Union taking industrial action if members of other unions were also planning to take action on this issue.
For now, however, the PDA Union will wait for other unions to publish the outcomes of their own consultations. As a union dedicated to representing the needs of only
pharmacists, the PDA has been able to quickly survey members immediately after the pay award was announced.
Rowlands Pharmacy has joined hands with healthcare software company HasHealth for an enhanced digital proposition to facilitate seamless delivery of a raft of
clinical services including flu and travel vaccinations.
The new system is now available across 400 Rowlands pharmacies across the UK.
The partnership comes as Rowlands Pharmacy strives to provide patients with a seamless booking experience whilst minimising time-consuming administration for pharmacy
staff, with its waiting list, medical pre-screen questionnaires and resource management capabilities, the company said in a statement.
HasHealth offers a virtual healthcare software solution that allows community pharmacies to schedule, manage, and communicate with patients easily online. It combines
its cutting-edge video technology with booking and management software, which can be adapted to any clinical service.
Nigel Swift, managing director at Rowlands Pharmacy, commented: "We pride ourselves on listening to our staff, based on feedback we knew we could do better with our
digital proposition for clinical services and flu vaccinations in particular.
The Department of Health and Social Care (DHSC) is encouraging people to come forward for their first and/ or second dose of the Covid vaccine before the free
offer ends on Friday (30 June).
The NHS's world-leading vaccination programme has so far delivered over 146 million Covid jabs.
Building on the success of autumn and spring booster programmes, a seasonal, targeted vaccination offer will remain open for those most at risk, in line with advice
from the Joint Committee on Vaccination and Immunisation (JCVI).
Health Minister Maria Caulfield said: "As we live with Covid without restrictions on our freedoms, it is right that we move towards a more targeted vaccination
offer that prioritises those most at risk, so we can focus our efforts on cutting waiting lists for NHS treatment - one of the Prime Minister's top five priorities.
As the offer for any adult to get a Covid vaccine comes to an end on 30 June, I would urge those who have not yet come forward to choose to have the first and second
Covid vaccine. It takes minutes to get your jab and thousands of sites are open across England."
This year's spring booster programme continues to gather pace, with over two million eligible people receiving their vital top-up dose.
Royal Pharmaceutical Society (RPS) and the Royal College of General Practitioners in Scotland hosted an event celebrating the collaborative work of the health
professions and policy makers in Scotland on reducing the environmental harm from prescribing and medicines use.
To share priorities for the Scottish Government, Alpana Mair, Head of Effective Therapeutics and Prescribing spoke and National Clinical Director Jason Leitch
appeared virtually. Gillian MacKay MSP, Scottish Greens spokesperson for Health and Social Care also joined in-person.
Medicines account for around 25% of the NHS's carbon emissions and have an ecological impact when they enter our wastewater system or our rivers and oceans.
Tackling the impact of prescribing will be a key part of meeting the ambition of a net zero NHS Scotland by 2040 at the latest.
Together, RCGP Scotland and RPS have held two roundtable events on sustainable prescribing, and in June 2022, released a joint statement calling for a wide range
of actions, which was signed by the Academy of Medical Royal Colleges and Faculties in Scotland, the Royal College of Physicians of Edinburgh, the Royal College of
Anaesthetists, the College of Radiographers, Royal College of Nursing, Queen's Nursing Institute Scotland and Chartered Society of Physiotherapy.
Continuing the work of RPS at the International Forum on Quality and Safety in Healthcare, the event aims to mark an opportunity for health professionals and
decision makers alike to join a global movement of sustainability in healthcare, and pledge to continue the important work of cutting the climate impact of medicine
use while maintaining the highest level of patient care and safety.
The UK must act swiftly to fend off competition if it wants to build the world's leading life sciences sciences hub, a new report suggests.
A year on from the launch of the government's life science vision, the report commissioned by the the Association of the British Pharmaceutical Industry said
although achieving the ambition remained feasible, the UK would need an attractive business environment because its competitor countries were becoming more adept
at attracting investment.
To achieve the ambition of the vision, the PwC-produced report suggested raising pharmaceutical R&D investment in the UK to build a 'stronger manufacturing and
research infrastructure', alongside better investment in, access to and uptake of innovative medicines.
It said the UK would also need to adopt a renewed approach to the priority healthcare challenges identified in the government's 'Life Science Vision', which would
mean cutting the overall burden on health of dementia, cancer, cardiovascular and respiratory disease and mental health.
The report quantified the size of the prize if the vision was implemented in full and the UK could emulate the successes of leading EU countries, which included:
£68 billion in additional GDP over 30 years, owing to increased R&D investment
£16.3 billion additional annual GDP from increased pharmaceutical exports
Supporting 85,000 additional jobs
Up to 40 per cent decrease in disease burden across the whole UK - for areas like cardiovascular disease, mental health conditions and Cancer.
Reduced variation in speed of access to new medicines within three months of licensing for all NHS patients.
Two dozen parliamentarians from across the political spectrum have called on the prime minister to act as a wave of pharmacy closures in recent years has
threatened to spiral out of control.
A letter to the prime minister signed by 24 MPs and peers has warned that worse could be yet to come after "spiralling business costs" and "year after year of real
terms funding cuts" have led to hundreds of pharmacy closures.
New data from the PSNC shows that over 639 local pharmacies have been lost in England since 2016.
"This is the equivalent to just short of one pharmacy closure per constituency", the cross-party group warned.
The letter comes as MPs came together at a parliamentary summit to call for pharmacies to be embraced as a "game-changer" for tackling healthcare backlogs and taking
pressure off other areas of the NHS. A 'Future of Pharmacy' event was attended by 53 parliamentarians on July 5 in the Palace of Westminster.
At the event parliamentarians heard directly from frontline pharmacists and representatives of pharmacy bodies where a map of constituency-specific pharmacy numbers
was also unveiled, with details of the number of pharmacy closures in MPs' local area.
After the government announced to award pay rise to pubic sector workers, pharmacy trade bodies have expressed their disappointment at the neglect shown
towards funding crisis in community pharmacy.
The National Pharmacy Association (NPA) chair, Andrew Lane, said: "Our sector can't help but feel utterly neglected after seven years of crushing real terms cuts
to pharmacy funding, amounting to half a billion pounds, and no hint of any relief to come.
"This week's public sector pay awards, which include a large number of our health service colleagues, highlight that there's an unresolved funding crisis in
community pharmacy which needs urgent attention."
"Four months into this financial year, there is as yet no clarity even on current arrangements."
"After stepping up to tackle Covid and keep the wheels on the NHS, the sector deserves better than to be neglected in this way," Andrew opines.
Eighty-five per cent of adults responding to a survey commissioned by the National Pharmacy Association (NPA) have agreed that community pharmacies are
underfunded and that the sector needs more investment to be able to do the work it does.
The survey of 1,000+ adults in England was carried out online between August 26 and 30 by an agency called Research Without Barriers (RWB) on behalf of the NPA.
Pharmacies in England are now paid less for providing NHS services than they were before the Covid-19 pandemic, after years of real terms cuts.
Seventy-four per cent respondents think it's unfair that community pharmacies in England have had no increase in funding for eight years, despite rising business
costs.
When asked whether it's fair or unfair that pharmacies in England are now paid less for providing NHS services than they were before the pandemic, 81 per cent of
people replied that it's unfair.
Community Pharmacy England (CPE) Chief Executive, Janet Morrison met with the new Pharmacy Minister, Dame Andrea Leadsom MP this week and discussed a
range of critical topics, including funding and pressures.
Janet informed the minister that community pharmacies continue to face immense financial pressures, and highlighted the need for an improved core contract.
She told the minister that 35-50 per cent real term cuts and rising costs have led to closures, consolidations and cashflow.
This has weakened the capacity for the network to respond to displaced patients, increased risk in terms of the safety of medicine supply, and led to loss of
service for communities in the most deprived areas, she said.
The UK Government is investing £100 million to accelerate the use of AI in life sciences and healthcare under a new mission.
UK Prime Minister Rishi Sunak announced the AI Life Sciences Accelerator Mission in his speech last week.
The new initiative will capitalise on the UK's unique strengths in securing "health data and cutting-edge AI."
It will also help to identify those at risk of "dementia" and will ensure that patients participate in the trials at the right time to develop new treatments
effectively.
Henceforth, it will provide us with better data on how well new therapies work.
Sunak said: "AI can help us solve some of the greatest social challenges of our time. AI could help find novel dementia treatments or develop vaccines for cancer."
India is a prime destination for liver transplants due to its excellent medical teams and liver transplant hospitals with affordable price in India compared to other developed countries.
The Pharmacists' Defence Association (PDA) Union has reached a deal for its members working at Boots, covering 6,000 pharmacists employed by the British retailer and pharmacy chain.
As per the agreement, union members working at the multiple will receive a 2 per cent pay rise effective from November 1, 2021, the two entities said in a joint statement.
The settlement, reached under the guidance of Advisory, Conciliation and Arbitration Service (ACAS), covers provisionally registered pharmacists, pharmacists and pharmacist store managers in the bargaining unit for which the PDAU is recognised.
There will be improved benefits for those at the beginning of their careers as "all pharmacists qualifying in 2021 will be paid at least £38k gross FTE, including those who would otherwise be ineligible due to the 1st August cut-off."
British scientists said on Thursday (December 30) they would be studying whether higher doses of a cheap and widely used steroid called dexamethasone could work better for patients with severe Covid-19 compared to the standard low doses.
Last year, the same scientists conducting the large trial, dubbed RECOVERY, showed that dexamethasone was able to save the lives of Covid-19 patients in what was called a "major breakthrough" in the coronavirus pandemic.
They had found that a 6 mg daily dose of dexamethasone, which is used to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill Covid-19 patients in hospitals.
"Given how quickly the Omicron variant is spreading, we can expect to see patients admitted to hospital with severe Covid-19 for a while to come," said Peter Horby, an Oxford University professor co-leading the trial.
Health technology pioneer Invatech Health has sold its care homes electronic medication administration record (eMAR) system Atlas to care home management
specialists Person Centred Software (PCS).
Following the transition of Atlas to new ownership, Bristol-based Invatech Health will concentrate solely on further growth of Titan, its cutting-edge software for pharmacy management.
Invatech Health CEO Tariq Muhammad, a pharmacist who started working on care homes back in 2002, first conceived the concept of electronic medicines system for care homes in 2006.
Muhammad said he was proud to see his purpose-driven business given an opportunity for further progress. "It's a bit like being at a child's graduation," he said,
after the completion of the acquisition which marked the end of a 20 year journey for him with Atlas.
"I set up Atlas to tackle a dire need in the care homes sector for a system which could prevent incorrect dosing, mismanagement of prescriptions and administration errors of important medication.
Women's health company Hertility has acquired the Netherlands-based fertility and hormone testing company Grip, increasing their market share in the women's health space and positioning them for rapid international expansion.
Hertility said the acquisition will expand its own dataset and help them reach their goal of drastically cutting down the time to diagnosis of female health conditions.
The UK start-up, launched in September 2020, offers a machine-learning healthcare solution, giving women insight on their reproductive health, through an at-home
hormone test, individual results and a route to care. Founded by scientists and powered by an (all female) research team, Hertility is building a science-backed eco-system of care around every woman.
Hertility is planning on launching in Ireland this summer and the Netherlands before the end of the year and is already offering end to end gynae and fertility care with a team of over 30 experts.
"This acquisition is a coming together of women who are on a mission to drive real change in women's health. We are over the moon to have taken Grip under our wing, and will be taking Hertility into new markets, starting with the Netherlands," Dr Helen O'Neill, founder of Hertility, commented.
The Pharmacists' Defence Association (PDA) has raised concern over the Health Education England (HEE)'s decision on cutting funding to independent prescribing
training.
The HEE has reportedly decided that no funding will be available to back-fill trainees undertaking the pharmacist independent prescribing (PIP) qualification, or
for the supervision of trainees by DPPs and DMPs.
The PDA noted that, whilst all successful trainee pharmacists will be entering the GPhC register as independent prescribers from 2026, the existing pharmacist
workforce is reliant on opportunities to undertake prescriber training through release from their employment, and the ability to secure a Designated Medical
Practitioner (DMP) or Designated Prescribing Practitioner (DPP) to support the 90 days of supervised practice required.
The association said it has already heard examples of potential DMPs or DPPs requesting a significant fee from trainees before they will provide supervision,
adding that meeting that request is not an option for many.
"This latest decision threatens to undermine the availability of the large numbers of pharmacists seeing supervisors as more IP training becomes available," it
said in a statement.
Titan PMR, a pioneer of cutting pharmacy technology has set up additional new team of 12 staff to cater for a deluge of independent pharmacists investing in
new businesses.
The company is utilising the opportunity that is underway as large chains look to sell off or close their community pharmacies, offering an opportunity for
pharmacists looking to provide efficient dispensing and additional services.
In January this year Lloyds Pharmacy, which was bought by a private equity firm in 2022, announced plans to close all its 237 branches inside Sainsbury's stores over
the course of 2023. Currently, more than 5,500 of around 14,000 registered pharmacy premises across the UK are owned by corporates and supermarkets.
Titan PMR - an innovative, cloud-based system which manages end-to-end pharmacy workflow - has become the preferred software platform especially amongst first time
buyers who are keen to offer new services to patients. The new team at the Bristol-based company, hired to support this sector, sees its total workforce growing to
more than 50 staff.
The Pharmacists Defence Association (PDA) has expressed its interest to support pharmacists impacted with the latest announcement of the closure of Tesco
pharmacies.
"Tesco have followed ASDA and LloydsPharmacy (at Sainsbury's) to announce cost cutting changes to their stores, impacting hundreds of jobs," the association said.
The PDA's interests in the announcement relate to the planned closure of eight in-store Tesco pharmacies and the impact of those closures upon pharmacists, however
the union is of course concerned for all those impacted.
The PDA Union will support individual PDA members impacted by the decision so that they are aware of, and can exercise, their rights at work in relation to this
situation.
Paul Day, PDA Union Director said, "In addition to the immediate impact on pharmacists employed at the stores marked for closure, this is the third instance in just
twelve days of reductions in the overall access to a pharmacy for NHS patients. We expect those who represent communities to be concerned about the loss of a key
part of their local NHS service."
The NHS is going to roll out a revolutionary 30-minute treatment for advanced womb cancer for women across England.
The drug, called Dostarlimab, would benefit around 100 women with advanced and often incurable endometrial cancer every year after the NHS agreed early access to the treatment through the Cancer Drugs Fund.
It works by attaching to a specific protein on the surface of the cancer cells, helping the immune system to detect and attack it.
The treatment takes just 30 minutes to administer through the blood stream every three weeks over a 12-week period.
The move is in line with the NHS Long Term Plan which aims to provide the latest cutting-edge treatments and therapies for patients.